Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
GRAHAM, DAVID
One or more keywords matched the following items that are connected to GRAHAM, DAVID
Item TypeName
Academic Article Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease.
Academic Article Rotavirus stability and inactivation.
Academic Article The interaction of pH, bile, and Helicobacter pylori may explain duodenal ulcer.
Academic Article High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection.
Academic Article Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Academic Article H. pylori in the pathogenesis of duodenal ulcer: interaction between duodenal acid load, bile, and H. pylori.
Academic Article Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
Academic Article Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
Academic Article Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors.
Academic Article Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH.
Academic Article Challenge model for Helicobacter pylori infection in human volunteers.
Academic Article Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Academic Article Early events in proton pump inhibitor-associated exacerbation of corpus gastritis.
Academic Article Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
Academic Article Antimony electrodes for in vivo pH monitoring.
Academic Article NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite.
Academic Article Ulcers and gastritis.
Academic Article Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Academic Article Schatzki's ring: to cut or break an unresolved problem.
Academic Article Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States.
Academic Article Characterization of the Helicobacter pylori urease and purification of its subunits.
Academic Article Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
Academic Article Helicobacter pylori outer membrane proteins and gastroduodenal disease.
Academic Article Duodenal ulcer promoting gene of Helicobacter pylori.
Academic Article Treatment of Helicobacter pylori in Latin America.
Academic Article Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer.
Academic Article Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.
Academic Article Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production.
Academic Article Efficient identification and evaluation of effective Helicobacter pylori therapies.
Academic Article Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication.
Academic Article Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.
Academic Article Understanding and appreciating sequential therapy for Helicobacter pylori eradication.
Academic Article Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study.
Academic Article Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
Academic Article Antimony electrodes. Mucosal potential differences and buffer composition adversely affect pH measurements in the stomach.
Academic Article Empiric therapies for Helicobacter pylori infections.
Academic Article In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.
Academic Article Helicobacter pylori: tailored therapy with novel sequential quadruple therapies.
Academic Article Minimal infective dose of rotavirus.
Academic Article How accurate is the determination of blood in gastric juice? Comparison of peroxidase and porphyrin methods.
Academic Article False negative urea breath tests with H2-receptor antagonists: interactions between Helicobacter pylori density and pH.
Academic Article Failures in a proton pump inhibitor therapeutic substitution program: lessons learned.
Academic Article Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.
Academic Article Long-term proton pump inhibitor use and gastrointestinal cancer.
Academic Article Optimal therapy for Helicobacter pylori infections.
Concept Hydrogen-Ion Concentration
Concept Proton Pumps
Concept Proton Pump Inhibitors
Concept Proton-Translocating ATPases
Academic Article Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China.
Academic Article Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.
Academic Article Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection.
Academic Article Helicobacter pylori diagnosis and management.
Academic Article Is real-time testing for helicobacter pylori and corpus atrophy clinically useful in 2005?
Academic Article Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.
Academic Article Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?
Academic Article Helicobacter pylori infection.
Academic Article Early heartburn relief with proton pump inhibitors and the marketing of zegreid.
Academic Article Evidence-based recommendations for successful Helicobacter pylori treatment.
Academic Article Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate.
Academic Article High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections.
Academic Article A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers.
Academic Article Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
Academic Article Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites.
Academic Article Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.
Academic Article Letter: bismuth, levofloxacin, amoxicillin, PPI quadruple therapy is not an effective first or second line regimen in the presence of levofloxacin resistance.
Academic Article How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.
Academic Article Helicobacter pylori: New Thoughts and Practices.
Academic Article Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
Academic Article Hybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis.
Academic Article Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
Academic Article Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
Academic Article Helicobacter pylori therapy: a paradigm shift.
Academic Article Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
Academic Article Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
Academic Article Increasing role for modified bismuth-containing quadruple therapies for Helicobacter pylori eradication.
Academic Article New Insight Into an Effective Treatment of Marginal Ulceration After Roux-en-Y Gastric Bypass.
Academic Article Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.
Academic Article Helicobacter pylori infection and antibiotic resistance: a WHO high priority?
Academic Article Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?
Academic Article Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
Academic Article Illusions regarding Helicobacter pylori clinical trials and treatment guidelines.
Academic Article Helicobacter pylori management in ASEAN: The Bangkok consensus report.
Academic Article Update on the Use of Vonoprazan: A Competitive Acid Blocker.
Academic Article Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency.
Academic Article Proton pump inhibitor therapy after Helicobacter pylori eradication may increase the risk of gastric cancer.
Academic Article Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial.
Academic Article Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies.
Academic Article Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better?
Academic Article Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.
Academic Article Pantoprazole in Patients in the ICU.
Academic Article Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment.
Academic Article Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus?) and a Proton-Pump Inhibitor.
Academic Article High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial.
Academic Article Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera? or Lactobacillus reuteri for treatment na?ve or for retreatment of Helicobacter pylori. Two randomized pilot studies.
Academic Article 14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment.
Academic Article PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis.
Academic Article Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial.
Academic Article Stress Ulcer Prophylaxis for ICU Patients.
Academic Article Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance.
Academic Article Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.
Academic Article Recent Developments Pertaining to H. pylori Infection.
Academic Article Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study.
Academic Article Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis.
Academic Article Quality of Studies for Gastric pH Measurements With Vonoprazan.
Academic Article Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe.
Academic Article Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study.
Academic Article Response to: a true point-of-care molecular testing method for tailored therapy for Helicobacter pylori eradication.
Academic Article Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates.
Academic Article Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.
Academic Article Controversies regarding management of Helicobacter pylori infections.
Academic Article Pilot studies of vonoprazan-containing Helicobacter pylori eradication therapy suggest Thailand may be more similar to the US than Japan.
Search Criteria
  • Protons